论文部分内容阅读
早产儿和新生儿中静脉内应用免疫球蛋白(IVIG)的理论基础是基于这类小儿发生感染的危险增高。他们从母体获得的抗体不完全、对某些抗原产生抗体的反应缓慢、有生理性低γ-球蛋白血症(特别是极早产
The rationale for the intravenous administration of immunoglobulin (IVIG) in preterm and neonates is based on the increased risk of infection in these children. They obtained from the mother’s antibody is not complete, antibodies to some antigens slow response, there is physiological low gamma-globulin (especially very premature